Prostate Cancer: is a cancer in a man's prostate, a small walnut-sized gland that produces seminal fluid. Some types of prostate cancer grow slowly, and other types are aggressive and require radiation, hormone therapy, surgery, chemotherapy, or other treatments. 
            
            
            
         
     
    
        
                    
                                    
                
         
                
                    
                                        
                        
                    
                            - 
                    
                                                                    
                                    
                                        
    
    
    
        This presentation discusses the advantages and disadvantages of robotic surgery. The initial goals for a robotic prostatectomy will be discussed as well as patient expectations and outcomes.&...
     
 
 
                                    
                                                                    
                                    
                                        
    
    
    
        The management of prostate cancer (PCa) continues to evolve and does so at a rapid rate. Research and technological developments continue to refine our definitions and management of this comp...
    
    
            
     
                                     
                                    
                                                                    
                                    
                                        
    
    
    
        The burgeoning area of molecular risk assessment (gene expression profiling and/or proteomic tests) in the diagnosis and treatment of prostate cancer is rapidly illuminating how clinicians mi...
    
    
            
     
                                     
                                    
                                                                    
                                    
                                        
    
    
    
        The landscape for treatment options in metastatic castration resistant prostate cancer has changed dramatically since 2010. There have been more therapies approved since 2010 than in the prio...
    
    
            
     
                                     
                                    
                                                                    
                                    
                                        
    
    
    
        We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...